Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Prospective Study: the Impact of Sleep Disturbances on Immunotherapy in Patients With Lung Cancer

NCT06953765 is registered in ClinicalTrials.gov with Shanghai Zhongshan Hospital as lead sponsor.

NCT NCT06953765
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06953765 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Prospective Study: the Impact of Sleep Disturbances on Immunotherapy in Patients With Lung Cancer
Lead sponsor
Shanghai Zhongshan Hospital
Phase
Observational
Overall status
Not yet recruiting
Start date
June 1, 2025
Completion date
December 30, 2028
Enrollment
350 (estimated)
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

lung cancer (nsclc), pd-1, sleep disorders, circadian rhythm